- This event has passed.
Symposium: Getting Real (World) with Psoriasis: Advances in Registries and Real-World Data in Psoriasis
Agenda
PART I: LECTURES
Introduction to the IPC and Program Overview
Joel Gelfand
Real-World Data Using Medical and Administrative Records
April Armstrong
Registries and Psoriasis: An Industry Perspective
Steven Fakharzadeh
Real-World Data and Psoriasis: A European Perspective
Nick Reynolds
PART II: KEYNOTE
Innovations in Real-World Data
Alexis Ogdie
Panel Discussion
Joel Gelfand & Faculty
PART III: POSTER PRESENTATIONS
Your Pores and the Outdoors: Investigating the Association between Pollution and Inflammatory Dermatological Diseases
Manan Mehta, BS, – University of Southern California Keck School of Medicine, Los Angeles, California, United States
Understanding Health Disparities among Patients with Psoriasis: Results from National Psoriasis Foundation Annual Surveys 2019 – 2021
George Gondo, MA – National Psoriasis Foundation, Portland, Oregon, United States
Psoriasis Resolution in Challenging Body Areas with Lxekizumab: Response Trajectories by Patient Profile Clusters Over Time
Andrew Blauvelt, MD, MBA – Oregon Medical Research Center, Portland, Oregon, United States
The Patient Perspective on Vaccine Uptake in Adults with Psoriasis and Eczema
Megan H. Noe, MD, MPH, MSCE – Brigham and Women’s Hospital, Boston, Massachusetts, United States
Kullback-Leibler Divergence Model to Integrate Genetic and Genomic Information to Assess Drug Response for Psoriatic Patients
Qinmengge Li, BS, MS – University of Michigan, Ann Arbor, Michigan, United States
A Systems Biology Analysis of Peripheral Blood and Cell Subsets from Patients with Psoriasis and Psoriatic Arthritis Reveals Biological Sex-Based Endotypes
Cheryl Cameron, PhD – Case Western Reserve University, Cleveland, Ohio, United States
HDL Composition, Particle Number and Size is Associated with Non-Calcified Coronary Plaque in Psoriasis
Álvaro Gonzales-Cantero, MD, PhD – Hospital Ramón y Cajal, Madrid, Spain
A Novel Expression Based, Non-Invasive Method to Differentiate Atopic Dermatitis and Psoriasis
Michael D Howell, PhD – DermTech Inc., La Jolla, California, United States
Closing Comments and Adjourn
Joel Gelfand
Program Chair
Joel Gelfand, MD, MSCE
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Treasurer
BioProgram Faculty
Supported in part by lead sponsor, Eli Lilly and Company, and supporting sponsors, Bristol Myers Squibb and Dermavant.
